https://www.aacr.org/patients-caregivers/progress-against-cancer/new-formulation-of-nivolumab-allows-subcutaneous-injection/
New Formulation of Nivolumab Allows Subcutaneous Injection | Research | AACR
Feb 12, 2025 - The FDA approved nivolumab and hyaluronidase-nvhy (Opdivo Qvantig) as a subcutaneous injectable therapy for multiple tumor types.
new formulationsubcutaneous injectionnivolumaballowsresearch
https://www.gov.uk/drug-safety-update/tazocin-piperacillin-tazobactam-new-formulation
Tazocin (piperacillin/tazobactam): new formulation - GOV.UK
Tazocin (piperacillin/tazobactam) has been reformulated to meet European Pharmacopoeia requirements on particle size.
piperacillin tazobactamnew formulationtazocinuk
https://www.news-medical.net/drugs/Loette-(New-Formulation).aspx
Loette (New Formulation) Drug / Medicine Information
Consumer Medicine Information (CMI) about Loette (New Formulation) intended for persons living in Australia.
new formulationloettedrugmedicineinformation
https://cal.com/drjuliansass/new-client-consultation
New Formulation Client Consultation | Dr. Julian Sass | Cal.com
New Formulation Client Consultation
new formulationclient consultationdrjuliansass